Matches in Nanopublications for { ?s ?p "[Attenuation of MAP3K9 function in melanoma cells using siRNA led to increased cell viability after temozolomide treatment, suggesting that decreased MAP3K pathway activity can lead to chemoresistance in melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- assertion description "[Attenuation of MAP3K9 function in melanoma cells using siRNA led to increased cell viability after temozolomide treatment, suggesting that decreased MAP3K pathway activity can lead to chemoresistance in melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Attenuation of MAP3K9 function in melanoma cells using siRNA led to increased cell viability after temozolomide treatment, suggesting that decreased MAP3K pathway activity can lead to chemoresistance in melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP949138.RAc7V_XFGmAc6rhInAx5ApkZqBdpew6MAYY_5iwjAycKA130_assertion description "[Attenuation of MAP3K9 function in melanoma cells using siRNA led to increased cell viability after temozolomide treatment, suggesting that decreased MAP3K pathway activity can lead to chemoresistance in melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP949138.RAc7V_XFGmAc6rhInAx5ApkZqBdpew6MAYY_5iwjAycKA130_provenance.
- NP558785.RAnuUeLHwBJY24rPYiNrAxAHEL6QqK-A3VozzpRVPjfrI130_assertion description "[Attenuation of MAP3K9 function in melanoma cells using siRNA led to increased cell viability after temozolomide treatment, suggesting that decreased MAP3K pathway activity can lead to chemoresistance in melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP558785.RAnuUeLHwBJY24rPYiNrAxAHEL6QqK-A3VozzpRVPjfrI130_provenance.
- NP21501.RAPDw0oGRB8BvxicWgyV07M22JKMkLiO6teIB4JdGumJs130_assertion description "[Attenuation of MAP3K9 function in melanoma cells using siRNA led to increased cell viability after temozolomide treatment, suggesting that decreased MAP3K pathway activity can lead to chemoresistance in melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP21501.RAPDw0oGRB8BvxicWgyV07M22JKMkLiO6teIB4JdGumJs130_provenance.